Pancreatic Cancer's Survival Wall Just Cracked: Daily Pill Nearly Doubles Survival
A once-daily pill cut the risk of death by 60 percent in metastatic pancreatic cancer — 13.2 months versus 6.7 months on chemotherapy. The FDA could review it within months.
Carl Sage